SCHEMBL2400178

SCHEMBL2400178

COc1ccc(/C=C/c2ccc(C(=O)O)cn2)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.64
XDH P47989 2/20 0.58
CA1 P00915 1/20 0.54
CA2 P00918 1/20 0.54
F3 P13726 3/20 0.53
ALDH1A1 P00352 3/20 0.52
CYP3A4 P08684 2/20 0.52
RAB9A P51151 3/20 0.52
NPC1 O15118 2/20 0.52
KDM4E B2RXH2 2/20 0.52
PKM P14618 1/20 0.52
THRB P10828 1/20 0.51
ATM Q13315 1/20 0.51
LMNA P02545 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
MAOB P27338 3/20 0.49
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49
HSPD1 P10809 1/20 0.49
TNFRSF1A P19438 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2400180 1.00 MAPT (0.64) MAPTXDHCA1CA2F3
SCHEMBL2400709 0.87 MAPT (0.62) MAPTCA1CA2F3ALDH1A1
SCHEMBL2400706 0.87 MAPT (0.62) MAPTCA1CA2F3ALDH1A1
SCHEMBL11715561 0.84 ALDH1A1 (0.47) MAPTXDHALDH1A1KDM4ELMNA
SCHEMBL5692873 0.84 XDH (0.78) MAPTXDHCA1CA2F3
SCHEMBL5692868 0.84 XDH (0.78) MAPTXDHCA1CA2F3
SCHEMBL26643182 0.83 MAOB (0.54) MAPTALDH1A1CYP3A4NPC1LMNA
SCHEMBL31516525 0.83 MAOB (0.54) MAPTALDH1A1CYP3A4NPC1LMNA
SCHEMBL11472328 0.81 MEN1 (0.52) ALDH1A1RAB9ANPC1KDM4ELMNA
SCHEMBL11472332 0.81 MEN1 (0.52) ALDH1A1RAB9ANPC1KDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250313546-A1 NUCLEIC ACID BINDERS UNIVERSITY OF STRATHCLYDE (GB) 2025-10-09 US disclosed
EP-4522588-A1 NUCLEIC ACID BINDERS University of Strathclyde (GB) 2025-03-19 EP disclosed
CN-119585239-A Nucleic acid binding agents 斯特拉斯克莱德大学 2025-03-07 CN disclosed
WO-2023218194-A1 NUCLEIC ACID BINDERS UNIVERSITY OF STRATHCLYDE (GB) 2023-11-16 WO disclosed
EP-2066627-B1 NOVEL MINOR GROOVE BINDERS UNIV STRATHCLYDE (GB) 2013-10-23 EP disclosed
US-8012967-B2 Minor groove binders UNIVERSITY OF STRATHCLYDE (GB) 2011-09-06 US disclosed
US-20100016311-A1 NOVEL MINOR GROOVE BINDERS UNIVERSITY OF STRATHCLYDE (GB) 2010-01-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100016311-A1 NOVEL MINOR GROOVE BINDERS TOP2B, DNA2, CTCF MAPT 2452/4885XDH 1501/4885CA1 4091/4885
US-20250313546-A1 NUCLEIC ACID BINDERS ZFR, NSUN3, POLI MAPT 2605/4885XDH 3376/4885CA1 4603/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.